Resultados de la búsqueda 591-600 of 7065 for Genetic Counseling

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Further, these gains have been the result of interventions during the Consolidation (tandem autologous stem cell transplant) and Post-Consolidation (dinutuximab ...

3. Mayo Clinic Orthopedic Surgery Physician Update — April 2025

   Page 1.

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Testing the Addition of an Anti-cancer ...

6. HR Recruitment-Relocation Insert - MC5152-11

   Page 1. Page 2.

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...

9. Mayo Clinic

   Share · Tweet . VID-20193984. Inicio; Genetic Bone Diseases in Children. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...